COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. - Wikidata - wikimedia - TriplyDB

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

http://www.wikidata.org/entity/Q35637295

about

Biomarkers in chronic obstructive pulmonary disease: confusing or useful?Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity Comparative effects of dexamethasone and bergenin on chronic bronchitis and their anti-inflammatory mechanisms based on NMR metabolomics.The association between risk of airflow limitation and serum uric acid measured at medical health check-ups Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease.The PROTECCT-M study: a cohort study investigating associations between novel specific biomarkers, patient-related, healthcare system markers and the trajectory of COPD patients treated in primary care Significance of the microbiome in chronic obstructive pulmonary disease.Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome Role of serum and induced sputum surfactant protein D in predicting the response to treatment in chronic obstructive pulmonary disease.Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.Determinants of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease: a prospective cohort study.Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease.Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values Genome-wide association study of lung function phenotypes in a founder population.Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls Muscarinic M3 receptors on structural cells regulate cigarette smoke-induced neutrophilic airway inflammation in mice Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease.Utility of the CAT in the therapy assessment of COPD exacerbations in China.Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality - a cohort study Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease.LC-MS based metabolomics identification of novel biomarkers of tobacco smoke-induced chronic bronchitis.Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients.Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study.The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD.Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD.Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls.Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease A novel flow cytometric-based method to measure kinase inhibition in sputum from COPD subjects.Factors associated with change in exacerbation frequency in COPD Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study.High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.Lessons from ECLIPSE: a review of COPD biomarkers.Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease.

P2860

Q27690280-203F6BE2-E85C-462F-98C2-C580CCB50E5C Q28484224-7FCF2442-E205-4262-8568-541057BD6306 Q28728578-D06EAE17-0FF3-46BF-B572-4D79B8733A85 Q31081933-94216B98-8847-4E28-98D0-0C7428591B69 Q33596469-480E68D7-ED86-47A6-B87D-B792832AA43B Q33705867-C3EDC402-6F74-4EE5-9317-34206806F453 Q33726236-3D6D202F-DC33-43C3-9535-32A8C65BC2FD Q33817613-AA0FF47A-C6A7-43AE-B60C-949AA77684D4 Q33831583-4A68DA91-5679-4963-B44B-C0E8E9FE3560 Q34119539-923B1268-1AC8-4591-A75F-D698535CDEB6 Q34252132-1CF4E191-99EA-4994-83D6-1318D9D6AE87 Q34287954-4473BA26-6D26-49AB-82E7-CAEC231E42BE Q34636461-5EE87362-B908-4D70-8314-13CCC0B02E4C Q34676003-9839ED2F-89AB-4853-8B1B-A0838C742B77 Q34676410-04AE3DDB-4486-4EF3-9CA9-D69CF27677F1 Q34729737-0EEDAD78-7359-4929-9E2C-53C0B999866A Q35042664-B2F850E4-C9EA-48D0-9DDD-21F0BEB69D19 Q35043468-C80654E4-9CB7-4DD4-A0D8-F672A5635179 Q35077055-30471770-3F87-4C83-BD00-CD23177DA95D Q35117371-58057B6F-C21A-4E27-8C47-FF9E3C7E1979 Q35530179-2EE203E1-3D01-4093-B6F1-C78E6BEC362F Q35531955-B1AAEF1B-D023-4E56-B612-D6E13C2846F4 Q35781857-FB0F93CB-CCCB-4C7B-B261-9672F9D29582 Q35935690-66BA9AB5-F3AD-4665-9A1B-663FBF115B7A Q35948272-76140EEE-A741-4761-986E-535FB52F99EB Q36288980-3D6CE67C-A1E2-4AB7-B932-03FF477D5F10 Q36383938-EE33BE9D-766C-4D49-AF66-2535C2884568 Q36585746-740651F9-1F96-4E71-8596-C2500D2A5839 Q36765593-588D1AAA-3AC7-4C81-8936-2353966278EB Q37012728-D3406E66-FEA4-497B-8245-326BD7F5C71E Q37063651-ABA128F9-F56D-46EC-9301-DE33DF440BDF Q37071132-53D6AE25-E27F-4F0F-9F3D-4455D485E215 Q37113883-4C5AAE5F-763E-473C-B700-2CA674D0FEC1 Q37311290-22D7E99B-E1DA-406A-93FC-56286E37E740 Q37501498-19E58678-5360-4078-B886-2B2EC4989FB6 Q37709578-7C585811-F361-43D2-BCBF-4097FBD47925 Q38056532-719F8AD1-B1FE-432B-ADE6-F85C76EB16AC Q38169066-949951CC-CCCF-4ACD-BBC0-58C5C1D9C02F Q38644007-7BF3EEA1-BB84-44AC-BD5F-08C1BF947FEC Q38649641-A4A31AE1-2D99-422C-B559-5A7E9CD66043

P2860

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

http://www.wikidata.org/entity/Q35637295

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

@ast

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

@en

type

label

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

@ast

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

@en

prefLabel

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

@ast

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

@en

P1433

Q35637295-97E53B76-2648-485D-A0E5-4820E52CAA1E

P1476

Q35637295-77F3EA44-B0BA-483D-A994-BA7575FE11FC

P2093

Q35637295-00412B1C-ECB8-4F90-B84A-68018AB42E60

Q35637295-452F11F5-B556-44FB-8E67-61C073EF8A83

Q35637295-73DC990E-8FE0-4526-AEAF-149832F9988F

Q35637295-C5E23AD6-EA94-4E1D-A5F9-1F09366681E3

Q35637295-FDDD2DC1-48C4-416D-A9DD-879766E77F3E

Q35637295-FF0F980C-D296-4677-BEBE-0478008F56B1

P2860

Q35637295-066F2B9B-5979-4A7F-9EB5-DFFA9F4669F5

Q35637295-08446A93-C96B-4C32-A7A3-8342B6D81DC3

Q35637295-0C31FF25-415C-4728-83DA-DF0B388452B1

Q35637295-2C8EFC46-AC71-4790-A3CF-6F3BB960861C

Q35637295-2D8BCCFF-2FDB-4568-A040-CF5136EE91EE

Q35637295-2DAD3C73-6DDE-4DA1-B336-314AC13A34F5

Q35637295-3FDEA535-1C70-4FDA-829D-CA7CBF733AC2

Q35637295-415180D1-5238-4D53-9336-A0DD4BBFEAA3

Q35637295-41F368ED-5E71-40F7-8E6D-5D184D897590

Q35637295-51C9B2BC-84BB-43A1-828F-A3A0C4357DB0

P2888

Q35637295-2718F0CC-22AB-47BE-B639-9B7ADE85462D

P304

Q35637295-EB3E0FC7-3597-4D36-BE57-1F83422A5AA6

P31

Q35637295-80D05217-2107-4AFC-856B-CC7E72BA1724

P356

Q35637295-065E1D66-3FC7-4057-B2E7-7CC995AB52B5

P478

Q35637295-5850085C-EA00-410B-BA87-3629F201E3C9

P50

Q35637295-4D96238D-91DC-4605-B538-AD727ED36897

P577

Q35637295-04EF13DC-0FBA-4433-B7A9-09E85814FF24

P5875

Q35637295-6BFA5072-5352-4894-B938-8EC74A4ABD5F

P6179

Q35637295-953EE011-5EA1-4D9F-860B-FF0E5DBE70F2

P698

Q35637295-F6EDD1B2-EB9F-45DC-B31F-7838CC8FD357

P921

Q35637295-AA38A597-73A6-4EF4-A836-20C60AE12EF5

Q35637295-E3E884A9-71C0-4461-8E4C-FA1C8A89014F

P932

Q35637295-80DF7AB2-22B8-4C06-8CFE-5AECB42B1510

P356

1465-9921-12-146

P1433

Respiratory Research

P1476

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

@en

P2093

Bruce E Miller

http://www.w3.org/2001/XMLSchema#string

David A Lomas

http://www.w3.org/2001/XMLSchema#string

Edwin K Silverman

http://www.w3.org/2001/XMLSchema#string

Evaluation of COPD Longitudina ...... (ECLIPSE) study investigators

http://www.w3.org/2001/XMLSchema#string

Jennifer A Dickens

http://www.w3.org/2001/XMLSchema#string

Lisa D Edwards

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair

Myeloperoxidase.

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.

Adjusting for multiple testing--when and how?

Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.

Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease.

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

P2888

1465-9921-12-146

P304

146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-12-146

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Ruth Tal-Singer

P577

2011-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51770654

http://www.w3.org/2001/XMLSchema#string

P6179

1045002274

http://www.w3.org/2001/XMLSchema#string

P698

22054035

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

3247194

http://www.w3.org/2001/XMLSchema#string